FDA Inspection 1257612 — Partner Therapeutics, Inc.
The FDA completed an inspection of Partner Therapeutics, Inc. on Dec 4, 2024 in Lexington, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 4, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lexington, MA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)